Relapse localization in Burkitt lymphoma/leukemia patients who achieved CR (n = 319)
| . | Relapse patients . |
|---|---|
| Total Localization | 37 (12) |
| CNS ± other | 12 (4) |
| Age <55 y | 7 |
| Age >55 y | 5 |
| CNS, isolated | 5 (2) |
| Age <55y | 2 |
| Age >55y | 3 |
| Bone marrow ± other | 9 (3) |
| Age <55 y | 4 |
| Age >55 y | 5 |
| Lymph nodes | |
| Lymph nodes | 2 |
| Lymph nodes + other | 2 (intestine/lung) |
| Extranodal sites | |
| Gastrointestinal | 2 |
| Bone | 1 |
| Muscle | 1 |
| Skin | 2 |
| Pararenal | 1 |
| . | Relapse patients . |
|---|---|
| Total Localization | 37 (12) |
| CNS ± other | 12 (4) |
| Age <55 y | 7 |
| Age >55 y | 5 |
| CNS, isolated | 5 (2) |
| Age <55y | 2 |
| Age >55y | 3 |
| Bone marrow ± other | 9 (3) |
| Age <55 y | 4 |
| Age >55 y | 5 |
| Lymph nodes | |
| Lymph nodes | 2 |
| Lymph nodes + other | 2 (intestine/lung) |
| Extranodal sites | |
| Gastrointestinal | 2 |
| Bone | 1 |
| Muscle | 1 |
| Skin | 2 |
| Pararenal | 1 |
Values are n or n (%).